Literature DB >> 17726083

Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.

Rhonda Bentley-Lewis1, Gail K Adler, Todd Perlstein, Ellen W Seely, Paul N Hopkins, Gordon H Williams, Rajesh Garg.   

Abstract

CONTEXT: The mechanisms underlying obesity-mediated cardiovascular disease are not fully understood. Aldosterone and insulin resistance both are associated with obesity and cardiovascular disease.
OBJECTIVES: The objectives of this study were to test the hypotheses that aldosterone production is elevated and associated with insulin resistance in overweight adults on a high-sodium diet. PARTICIPANTS/
INTERVENTIONS: Healthy normotensive adults were categorized as lean body mass index (BMI) less than 25 kg/m(2) (n = 63) or overweight BMI 25 kg/m(2) or greater (n = 57). After 7 d of a high-sodium diet, participants fasted overnight and remained supine throughout hemodynamic and laboratory assessments and angiotensin II (AngII) stimulation.
RESULTS: The overweight group, compared with the lean group, had higher 24-h urinary aldosterone (9.0 +/- 0.8 vs. 6.6 +/- 0.5 microg per 24 h; P = 0.003) and higher AngII-stimulated serum aldosterone (11.4 +/- 1.0 vs. 9.0 +/- 0.6 ng/dl; P = 0.04). There were no differences in 24-h urinary cortisol or sodium or supine measurements of plasma renin activity, serum aldosterone, or serum potassium. The homeostasis model assessment of insulin resistance was predicted by urinary aldosterone excretion (r = 0.32, P = 0.03) and serum aldosterone response to AngII stimulation (r = 0.28, P = 0.02) independent of age and BMI.
CONCLUSION: Urinary aldosterone excretion and AngII-stimulated aldosterone are increased in overweight, compared with lean, normotensive adults. The correlation of these measures of aldosterone production with insulin resistance suggests a potential role for aldosterone in the pathophysiology of obesity-mediated insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726083      PMCID: PMC4428584          DOI: 10.1210/jc.2007-1088

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 2.  Mechanisms linking obesity with cardiovascular disease.

Authors:  Luc F Van Gaal; Ilse L Mertens; Christophe E De Block
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

3.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

4.  Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association.

Authors:  Robert H Eckel; Richard Kahn; Rose Marie Robertson; Robert A Rizza
Journal:  Circulation       Date:  2006-06-27       Impact factor: 29.690

5.  Role for aldosterone in blood pressure regulation of obese adolescents.

Authors:  A P Rocchini; V L Katch; R Grekin; C Moorehead; J Anderson
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

6.  Plasma aldosterone is independently associated with the metabolic syndrome.

Authors:  Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

Review 7.  Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.

Authors:  Richard N Bergman; Stella P Kim; Isabel R Hsu; Karyn J Catalano; Jenny D Chiu; Morvarid Kabir; Joyce M Richey; Marilyn Ader
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

8.  The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

Authors:  M L Tuck; J Sowers; L Dornfeld; G Kledzik; M Maxwell
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

9.  Genetic determinants of nonmodulating hypertension.

Authors:  Natapong Kosachunhanun; Steven C Hunt; Paul N Hopkins; Roger R Williams; Xavier Jeunemaitre; Pierre Corvol; Claudio Ferri; Richard M Mortensen; Norman K Hollenberg; Gordon H Williams
Journal:  Hypertension       Date:  2003-10-06       Impact factor: 10.190

10.  Familial aggregation of insulin resistance and cardiovascular risk factors in hypertension.

Authors:  Annaswamy Raji; Jonathan S Williams; Paul N Hopkins; Donald C Simonson; Gordon H Williams
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

View more
  98 in total

Review 1.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

2.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

3.  Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

Authors:  Vincenzo Marzolla; Andrea Armani; Caterina Mammi; Mary E Moss; Vittoria Pagliarini; Laura Pontecorvo; Antonella Antelmi; Andrea Fabbri; Giuseppe Rosano; Iris Z Jaffe; Massimiliano Caprio
Journal:  Int J Cardiol       Date:  2017-01-05       Impact factor: 4.164

Review 4.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

Review 5.  Cortisol dysregulation in obesity-related metabolic disorders.

Authors:  Rene Baudrand; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

6.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

Review 7.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

8.  Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Authors:  Tanja Dudenbostel; Lama Ghazi; Mingchun Liu; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

Review 9.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

10.  Increased aldosterone among HIV-infected women with visceral fat accumulation.

Authors:  Janet Lo; Sara E D Looby; Jeffrey Wei; Gail K Adler; Steven K Grinspoon
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.